v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities:      
Net loss $ (5,234,692) $ (3,809,700) $ (3,809,700)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock based compensation 1,510,259 2,954,279  
Change in fair value of investment in equity securities (5,601) (10,755)  
Amortization of debt discount and debt issuance cost 361,958  
Loss from change in fair value of common stock make-whole obligation 25,027 197,930  
Change in fair value of warrant liability 667,571 (1,699,177)  
Change in fair value of sponsor earnout shares (528,000)  
Non-cash marketing expense for proposed stock issuance to vendor 75,562  
Gain on extinguishment of liability (4,972)  
Depreciation expense 992 764  
Deferred transaction costs expensed 25,000  
Changes in operating assets and liabilities:      
Prepaid expenses and other assets 16,221 88,934  
Accounts payable 318,798 290,879  
Accrued liabilities and other current liabilities 178,575 (360,341)  
Net cash used in operating activities (2,065,302) (2,875,187)  
Cash flows from investing activities:      
Capital project costs (173,685) (959,644)  
Land acquisition cost (688)  
Purchase of property and equipment (1,151)  
Net cash used in investing activities (174,836) (960,332)  
Cash flows from financing activities:      
Proceeds from issuance of common stock 97,106 16,414  
Deferred transaction costs paid (25,000)  
Repayment of short-term loan from related parties (2,000,000)  
Repayment of short-term loan (101,555) (1,677,914)  
Proceeds from advance received from PIPE investors 125,000  
Proceeds from public offering 5,750,400  
Proceeds from warrant inducement exercises 2,971,040  
Transaction costs associated with public offering and warrant inducement (648,860)  
Net cash (used in) provided by financing activities (4,449) 4,511,080  
Net (decrease)/ increase in cash (2,244,587) 675,561  
Cash at the beginning of the period 3,480,151 912,574 912,574
Cash at the end of the period 1,235,564 1,588,135 $ 3,480,151
Supplemental disclosure for cash flow information:      
Interest paid 39,155 141,718  
Supplemental disclosure of non-cash investing and financing activities:      
Unpaid capital project costs 1,959 1,545,171  
Unpaid property and equipment purchase cost 380  
Reclass of advances to capital project costs 236,235  
Unpaid public offering issuance cost 652,312  
Unpaid warrant inducement issuance costs 29,000  
Unpaid amount for repurchase of unvested shares 1,593  
Pending stock issuance under licensing arrangement 343,000  
Incremental fair value of warrant inducement 2,108,480  
Fair value of common stock issued to settle accrued liability $ 1,573,032